Physician profile
Ginger Lane
NPI 1073663985
$2,768.41
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,002 · 2022: $295 · 2023: $1,062 · 2024: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,378 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,377.69 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $525.26 | 2021-2024 | Injectafer |
| Abbvie INC. | $419.74 | 2021-2023 | |
| Hologic Sales and Service, LLC | $349.20 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $280.14 | 2021-2023 | Slynd |
| Melinta Therapeutics, LLC | $247.60 | 2023 | Kimyrsa |
| Astellas Pharma US INC | $200.39 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $174.45 | 2023 | |
| Therapeuticsmd, INC. | $112.84 | 2021-2022 | |
| Pfizer INC. | $77.82 | 2021-2022 | |
| Organon LLC | $64.17 | 2021-2024 | Nexplanon |
| Agile Therapeutics, INC. | $50.34 | 2021-2022 | |
| Avion Pharmaceuticals | $45.09 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.77 | 2021-2023 | |
| Scynexis, INC. | $37.90 | 2022 | |
| Mylan Pharmaceuticals INC. | $30.85 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $24.43 | 2021 | |
| Merck Sharp & Dohme LLC | $21.89 | 2021 | |
| Evofem Biosciences, INC. | $18.98 | 2021 | |
| Myovant Sciences INC. | $16.25 | 2021 | |
| Coopersurgical, INC. | $16.15 | 2023 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $14.15 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.